Terminal2 — Card #28: Post-Cardiac Arrest / Anoxic Brain Injury

S01 Everyone

What Is It

Cardiac arrest, global cerebral ischemia, and the spectrum of anoxic brain injury. What happens when the heart stops and the brain goes without oxygen — and what it means for the family at the bedside.

US Cardiac Arrests/Year

~356K OHCA

~356,000 out-of-hospital cardiac arrests annually; ~290,000 in-hospital cardiac arrests. Cardiac arrest is among the most common life-threatening emergencies in the US.^[1]

Survival to Discharge

~10% OHCA

OHCA ~10%; IHCA ~25%. Survival has improved with CPR training, AED deployment, and post-resuscitation care but remains low.^[2]

Good Neurological Outcome

~8% OHCA

~8% OHCA; ~15–20% IHCA. The gap between surviving the arrest and surviving with good brain function defines the clinical problem.^[3]

Persistent Severe Impairment

15–30%

~15–30% of cardiac arrest survivors reaching ICU have severe permanent neurological impairment — the population whose families face the most difficult prognostic and goals-of-care conversations.^[4]

Cardiac arrest causes global cerebral ischemia — the complete cessation of oxygenated blood delivery to every neuron in the brain simultaneously. Unlike a stroke, which injures a focal territory supplied by a single occluded vessel, cardiac arrest deprives the entire brain of oxygen and glucose at once. After 4–6 minutes of complete ischemia, irreversible neuronal death begins in the most oxygen-sensitive regions: the hippocampus (memory), the Purkinje cells of the cerebellum (coordination), the basal ganglia (movement), and the watershed zones of the cerebral cortex (higher cognition). The depth and extent of injury depend on no-flow time (minutes without any circulation), the quality and timing of CPR, the time to return of spontaneous circulation (ROSC), the initial cardiac rhythm, and the quality of post-resuscitation management including targeted temperature management (TTM).^[5]

What emerges from this insult is not a single outcome but a spectrum of disorders of consciousness — from transient coma with full recovery, to minimally conscious state (MCS), to persistent vegetative state (VS), to brain death. This spectrum can take days to weeks to months to declare with any confidence. The multimodal prognostication approach — combining neurological examination, somatosensory evoked potentials (SSEP), EEG, serum biomarkers, and brain MRI — is the current standard, but even with all modalities, prognostic certainty in the first 72 hours is imperfect. The family told "the heart is beating but the brain is injured" must navigate decisions about life-sustaining treatment — ventilators, feeding tubes, tracheostomy — without understanding the difference between biological survival and meaningful recovery.^[6]

Post-cardiac arrest care has improved dramatically with TTM protocols, early coronary intervention, and standardized neuroprognostication guidelines. But improvement in resuscitation science has created a new population: patients who survive the arrest but are left with severe, permanent anoxic brain injury. These patients — and their families — are the population this card addresses. They will arrive at hospice from the ICU, from long-term acute care, or from skilled nursing facilities, often weeks to months after the arrest, often with tracheostomies and feeding tubes, and always with families who have been through an experience that no one can prepare for.^[7]

🧭 Clinical framing

The hospice and palliative care clinician entering this space must translate what the intensivist measured into what the family can understand and act on. The neurologist speaks in N20 responses, NSE levels, and GCS motor scores. The family speaks in "Will he wake up?" and "Can she hear me?" and "Is he suffering?" The central challenge of post-cardiac arrest palliative care is not medical — it is translational. The clinician who can bridge that gap is providing the most important service in the room.

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"The family in the ICU waiting room thinks the worst is over because the heart is beating again. It's not. The worst is about to begin — and it's going to be a conversation, not a code. You need to be in that room before the neurologist finishes the prognostic workup, not after."

— Waldo, NP · Terminal2

S02 Clinician

How It's Diagnosed

Neuroprognostication after cardiac arrest — the central clinical challenge. How the ICU team determines the severity of brain injury, and how to read that workup when the patient arrives at hospice.

Neurological Examination & Prognostic Tools

Serial neurological examination after rewarming from TTM: Must be performed ≥72 hours after ROSC and ≥24 hours after rewarming to avoid confounding by sedation and hypothermia. Glasgow Coma Scale (GCS) and FOUR score are standard assessment tools. Best motor response is the most prognostically significant component of the neurological exam.^[8]
Pupillary light reflexes: Bilaterally absent pupillary reflexes at 72 hours post-arrest have >95% specificity for poor neurological outcome. Quantitative pupillometry (Neurological Pupil index <2) provides objective, reproducible measurement and reduces interobserver variability.^[9]
Corneal reflexes: Bilaterally absent corneal reflexes at 72 hours also predict poor outcome, though with slightly lower specificity than pupillary reflexes. Should be tested with direct corneal stimulation, not just conjunctival touch.^[10]
Motor responses: GCS motor score of 1–2 (absent or extensor response) at 72 hours post-rewarming predicts poor outcome. However, motor examination alone has lower specificity (~75%) and should never be used as a sole prognostic indicator.^[8]
EEG: Malignant patterns include burst suppression, suppressed background (<10 μV), and generalized periodic discharges (GPDs). Absence of EEG reactivity to external stimuli is an independent predictor of poor outcome. Continuous EEG monitoring detects subclinical seizures including non-convulsive status epilepticus (NCSE), present in 10–30% of post-arrest patients. Diffuse alpha/theta coma pattern with absent reactivity indicates severe cortical injury.^[11]
SSEP (somatosensory evoked potentials): Bilateral absence of the N20 cortical response is the single most reliable predictor of poor neurological outcome after cardiac arrest. N20 absence at 24–72 hours post-rewarming carries specificity >99% for non-awakening, with a false positive rate approaching zero in the absence of confounders. This is the strongest single prognostic indicator available.^[12]

Imaging & Biomarkers

MRI brain (DWI/ADC mapping): Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping is the most sensitive imaging modality for anoxic brain injury. Diffuse cortical restricted diffusion indicates widespread neuronal death. Basal ganglia and thalamic signal changes on DWI indicate deep gray matter injury. Optimally performed at 48–72 hours post-arrest (peak sensitivity); imaging too early may underestimate injury extent. Limited by patient instability, incompatible devices, and logistical challenges of MRI transport in critically ill patients.^[13]
CT brain: Less sensitive than MRI but readily available. Primarily used to exclude structural causes (hemorrhage, mass lesion). Signs of anoxic injury on CT include diffuse cerebral edema, sulcal effacement, and loss of gray-white matter differentiation. Gray-white ratio (GWR) <1.15–1.2 at Hounsfield unit measurement is associated with poor neurological outcome. CT findings may lag behind the true extent of injury in the first 24 hours.^[14]
NSE (neuron-specific enolase): Serum biomarker of neuronal destruction. NSE >33 ng/mL at 24 hours or >60–90 ng/mL at 48–72 hours is associated with poor neurological outcome. Serial measurements showing a rising trajectory are more predictive than any single value. Critical limitation: hemolysis (from blood draws, CPR, or ECMO) causes false elevation; hemolysis index must be checked on every sample. Must always be interpreted in conjunction with other prognostic modalities — never in isolation.^[15]
Multimodal prognostication at 72 hours post-rewarming: The current standard per ERC/ESICM 2021 guidelines is a multimodal approach combining neurological examination + SSEP + EEG + NSE + MRI. No single test should be used in isolation. Two or more concordant predictors of poor outcome provide the highest prognostic confidence. This approach reduces the risk of self-fulfilling prophecy (premature WLST based on a single indicator) while providing families and clinicians with the most reliable information available.^[16]

💡 For families

💡 Para las familias

"The doctors are using several different tests together to understand how much the brain was affected. No single test gives the full picture. They are waiting for the right time — usually about 72 hours after the heart was restarted — to put all the information together and talk with you about what it means. This waiting is not wasted time. It is the most responsible thing the medical team can do."

"Los médicos están usando varias pruebas diferentes juntas para entender cuánto se afectó el cerebro. Ninguna prueba sola da el panorama completo. Están esperando el momento adecuado — generalmente unas 72 horas después de que el corazón volvió a latir — para reunir toda la información y hablar con usted sobre lo que significa."

S03 Everyone

Causes & Risk Factors

Why the heart stopped, what caused the brain injury, and the factors that determine who survives with what level of function. Answers the family's first question: "Why did this happen?"

Cardiac Causes of Arrest

VF/VT (shockable rhythms): Most commonly caused by acute myocardial infarction, severe coronary artery disease, dilated or ischemic cardiomyopathy, hypertrophic cardiomyopathy (HCM), and inherited arrhythmia syndromes including long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). VF/VT carries the best prognosis for neurological recovery because it responds to defibrillation and is associated with shorter no-flow times when witnessed.^[17]
PEA (pulseless electrical activity): Organized electrical activity on the monitor without effective cardiac output. Caused by the classic 6 Hs (hypovolemia, hypoxia, hydrogen ion/acidosis, hypo/hyperkalemia, hypothermia, hypoglycemia) and 6 Ts (tension pneumothorax, tamponade, toxins, thrombosis–coronary, thrombosis–pulmonary, trauma). Generally carries worse neurological prognosis than VF/VT because it often reflects a systemic process rather than a primary electrical event, and because resuscitation is less straightforward.^[18]
Asystole: Complete absence of electrical activity — a flatline. Carries the worst prognosis of any initial rhythm. Often represents the terminal manifestation of prolonged VF/VT or PEA that has deteriorated, or a primary asystolic arrest in the setting of massive parasympathetic surge, severe hyperkalemia, or prolonged hypoxia. Survival to discharge with good neurological outcome from primary asystole is <2%.^[19]

Non-Cardiac Causes & Risk Factors

Respiratory arrest preceding cardiac arrest: Hypoxia-driven cardiac arrest from COPD exacerbation, opioid overdose, status asthmaticus, near-drowning, airway obstruction, or neuromuscular respiratory failure. These patients may have worse neurological outcomes because the brain is hypoxic before the heart stops — the ischemic clock starts ticking before the cardiac arrest is even recognized.^[20]
Massive pulmonary embolism: Acute right heart failure and obstructive shock leading to cardiac arrest. Thrombolytic therapy during CPR may be indicated if PE is suspected.^[21]
Aortic catastrophe: Aortic dissection or ruptured aneurysm causing tamponade, hemorrhagic shock, or coronary malperfusion leading to arrest.
Metabolic causes: Severe hyperkalemia, hypokalemia, hypomagnesemia, severe acidosis, hypothermia, and drug toxicity (tricyclic antidepressants, digoxin, calcium channel blockers).^[18]
Risk factors for cardiac arrest: Prior cardiac arrest (highest risk), severe systolic dysfunction (EF <35%), prior MI with myocardial scar, inherited channelopathies (long QT, Brugada, CPVT), hypertrophic cardiomyopathy, family history of sudden cardiac death, severe valvular disease, and substance use (cocaine, methamphetamine).^[22]

❤️ For families: "Why did this happen?"

"Cardiac arrest happens when the heart's electrical system fails — suddenly, without warning, and often in people who had no idea anything was wrong. This was not something anyone could have predicted or prevented. The brain injury that followed was caused by the minutes the brain went without blood flow. Those minutes are measured in seconds. You could not have changed them. There is nothing you did wrong, nothing you missed, and nothing you could have done differently. The paramedics, the ER team, the ICU doctors — everyone did exactly what they were supposed to do. Sometimes the injury to the brain is more than medicine can fix."

⚕ Disparity note

Black Americans have significantly higher rates of OHCA and worse outcomes across every measurable indicator. Studies consistently demonstrate lower bystander CPR rates in predominantly Black neighborhoods, longer EMS response times, lower rates of shockable initial rhythms, lower rates of ICU admission post-arrest, and lower rates of targeted temperature management. These disparities persist after adjusting for socioeconomic status, comorbidity burden, and initial rhythm. They are systemic — rooted in neighborhood-level AED access, CPR training availability, EMS resource allocation, and implicit bias in post-resuscitation care decisions — not biological. The palliative care clinician should be aware that Black families navigating post-arrest prognostication may carry justified mistrust of the medical system, and that trust must be earned, not assumed.^[23]

S04 Clinician

Treatments & Procedures

The post-cardiac arrest treatment trajectory from resuscitation through ICU management to goals-of-care transitions. What the patient went through before arriving at hospice — and the decisions that remain.

The post-cardiac arrest patient has already been through the most aggressive medical intervention that exists. Their heart was restarted by CPR and defibrillation. They were intubated, sedated, cooled to 33–36°C for 24 hours, taken to the cardiac catheterization lab for coronary angiography, and maintained on vasopressors in an ICU. They had continuous EEG monitoring, serial neurological examinations, somatosensory evoked potentials, brain MRI, and serum biomarker testing. Every organ system was optimized — ventilation, hemodynamics, glucose, temperature, electrolytes — to give the brain the best possible chance to recover. The patient who arrives at hospice after cardiac arrest is not someone for whom "more could have been done." Everything was done. The brain injury that remains is the injury that medicine could not reverse.^[24]

Resuscitation & Post-Resuscitation Care

CPR: High-quality chest compressions at 100–120/min, depth 2–2.4 inches (5–6 cm), full chest wall recoil between compressions, minimal interruptions. The quality and timing of CPR is the single most important modifiable determinant of neurological outcome. Every minute without compressions reduces the probability of meaningful neurological recovery.^[25]
Defibrillation: For VF/VT, every minute of delay in defibrillation decreases survival by approximately 10%. Public-access AED deployment has improved outcomes for witnessed OHCA with shockable rhythms.^[26]
Targeted temperature management (TTM): Post-ROSC cooling to 33°C or 36°C for 24 hours was standard based on the 2002 HACA and Bernard trials. The TTM2 trial (2021) demonstrated equivalence between 33°C targeted hypothermia and 37.5°C normothermia with strict fever prevention. Current practice emphasizes aggressive fever prevention (<37.5°C) for at least 72 hours post-arrest as the minimum standard.^[27]
Coronary angiography: Immediate angiography for OHCA with suspected cardiac etiology and ST-elevation on post-ROSC ECG. PCI (percutaneous coronary intervention) if culprit lesion identified. Early angiography in non-STEMI OHCA remains debated (COACT trial showed no benefit of immediate vs. delayed angiography in OHCA without ST-elevation).^[28]
Hemodynamic optimization: MAP target ≥65–80 mmHg using vasopressors (norepinephrine first-line). Hypotension post-ROSC is independently associated with worse neurological outcomes — secondary brain injury from inadequate cerebral perfusion pressure compounds the primary anoxic insult.^[24]
Ventilatory management: Target SpO2 94–98% — hyperoxia (PaO2 >300 mmHg) is associated with increased oxidative stress and worse neurological outcomes. Target normocapnia (PaCO2 35–45 mmHg) — both hypocapnia (cerebral vasoconstriction) and hypercapnia (cerebral edema) are harmful.^[29]

Goals-of-Care Transitions

Prognostication at 72 hours post-rewarming: The multimodal prognostic assessment is completed using neurological examination, SSEP, EEG, NSE, and brain MRI. This is the pivotal moment when the ICU team and palliative care team meet with the family to discuss the findings and their implications for recovery. This meeting should never be rushed and should involve all relevant team members.^[16]
Time-limited trial framework: When prognosis is uncertain at 72 hours, a structured time-limited trial (7–14 days) with predefined clinical milestones and a specific reassessment date provides families with a framework for hope while preventing indefinite continuation of treatment that may not serve the patient. The TLT is the ethical bridge between "we don't know yet" and a definitive goals-of-care decision.^[30]
Palliative extubation protocol: When goals shift from cure to comfort, ventilator withdrawal follows a standardized comfort extubation protocol — premedication with morphine and midazolam, antisecretory agents, family preparation, and environmental modification. The patient may breathe independently for minutes to hours to days after extubation.^[31]
Tracheostomy and PEG decisions in the subacute phase: For patients who survive the acute ICU phase but remain in a disorder of consciousness, decisions about tracheostomy (for chronic ventilation or airway protection) and percutaneous gastrostomy tube (for long-term nutrition) arise in weeks 2–4. These decisions carry enormous emotional weight and should be framed as time-limited trials, not permanent commitments.^[32]
Transition from ICU to hospice or long-term care: Patients may transition directly from ICU to home hospice (after comfort extubation), to inpatient hospice, to long-term acute care (LTAC), or to skilled nursing facilities. The transition pathway depends on the level of medical technology in place (ventilator, tracheostomy, PEG), family capacity, and insurance coverage.^[33]
ICD deactivation: If the patient has an implantable cardioverter-defibrillator, deactivation of shock therapy is an essential comfort measure during the transition to hospice care. ICD shocks in a dying patient cause pain and distress to the patient and trauma to the family. Deactivation requires a magnet or device interrogation — hospice teams should have a magnet available and a clear protocol for emergency deactivation.^[34]

S05 Clinician

When Therapy Makes Sense

When continued aggressive intervention is appropriate after cardiac arrest. This card is unique — "therapy" here means continuing life-sustaining treatment, not traditional disease-directed therapy.

Post-cardiac arrest care is unlike any other diagnosis in this card series. There is no chemotherapy to continue or stop, no radiation field to plan, no targeted therapy to weigh. The "therapy" decisions here are about continuing aggressive post-resuscitation life support — mechanical ventilation, hemodynamic support, TTM, seizure management — versus transitioning to comfort-focused care. The palliative care clinician's role is not to advocate for stopping treatment, but to ensure that every day of continued aggressive care is serving the patient's interests and that the family understands what they are choosing. The decision framework is fundamentally different: in cancer, we ask "will this treatment extend quality life?" In post-cardiac arrest care, we ask "is this brain going to wake up?"^[30]

01

Aggressive post-resuscitation care including TTM in the first 24–72 hours: This is standard ICU care and is not a goals-of-care decision — it is the minimum standard for every post-arrest patient who achieves ROSC. Palliative care supports the ICU team during TTM by preparing families for the prognostic conversation that will follow rewarming, not by questioning whether TTM should be provided.^[27]
02

Coronary revascularization post-arrest if STEMI or ACS: Treating the reversible cardiac cause — the coronary occlusion that triggered the arrest — improves survival and potentially neurological outcome, even when the neurological prognosis is not yet known. Early PCI is appropriate regardless of neurological status in the first 24 hours because (a) the cardiac cause is treatable and (b) prognostication is unreliable in the first 72 hours. Withholding cardiac intervention based on premature neurological pessimism is a documented cause of preventable death.^[28]
03

Time-limited trial in patients with uncertain prognosis at 72 hours: The TLT framework defines a specific timeframe (7–14 days for anoxic brain injury), specific clinical milestones (eye opening, visual tracking, command following, meaningful motor response), and a specific reassessment date. "We will continue all current treatment for 14 days and reassess on [specific date]. During this time we will watch for [milestones]. If these milestones are not met, we will have another family meeting." The TLT allows families to experience hope within a structured decision-making framework, reducing both premature withdrawal and indefinite continuation of futile treatment.^[30]
04

Seizure management: Non-convulsive seizures and non-convulsive status epilepticus (NCSE) occur in 10–30% of post-arrest patients and cause ongoing neuronal injury. Untreated seizures worsen the neurological outcome that is already compromised. Levetiracetam is first-line for prophylaxis and treatment; continuous EEG monitoring is the only way to detect subclinical seizure activity. Aggressive seizure management is appropriate even in patients with uncertain prognosis because seizures are a treatable secondary injury that may be masking recovery potential.^[35]
05

Treatment of reversible secondary complications: Fever, hypotension, hyperglycemia, hyponatremia, and infection all worsen secondary brain injury and are fully treatable. Maintaining normothermia, adequate cerebral perfusion pressure, euglycemia, and electrolyte homeostasis is not "aggressive care" — it is preventing additional harm to an already injured brain. These interventions remain appropriate even during time-limited trials.^[29]
06

Surrogate explicitly desires continued aggressive care with full understanding of prognosis: A well-informed surrogate decision-maker who has received complete prognostic disclosure, has had adequate time to process the information, understands the full spectrum of possible outcomes including permanent vegetative state, and still chooses continued life-sustaining treatment deserves that choice without judgment. Autonomy — exercised through a surrogate — is paramount. The palliative care team's role is to ensure the decision is informed, not to override it.^[36]

S06 Clinician

When It Doesn't

When the evidence shows that continued life-sustaining treatment is prolonging dying, not supporting recovery. Recognizing this is not failure — it is the most important clinical skill in post-arrest care.

There is no "giving up" in post-cardiac arrest care. When the evidence shows that the brain injury is severe and permanent, withdrawing life-sustaining treatment is not giving up on the patient — it is giving up on a treatment that is extending the dying process rather than restoring the life. The ventilator that kept the patient alive during TTM and prognostic workup was an appropriate bridge to a decision. Once that decision has been informed by the best available evidence, continuing the ventilator in a patient with no prospect of meaningful neurological recovery is not an act of hope — it is an act of technology applied without purpose. The palliative care clinician must be able to articulate this distinction clearly, repeatedly, and without apology.^[37]

01

Bilateral absent N20 SSEP responses at 72 hours post-rewarming: Specificity >99% for non-awakening. This is the strongest single prognostic indicator available in post-cardiac arrest care. In the absence of confounders (deep sedation, neuromuscular blockade, severe peripheral neuropathy), bilateral N20 absence alone justifies a comfort-focused recommendation. When this finding is present alongside other concordant indicators, prognostic certainty approaches 100%.^[12]
02

Absent pupillary reflexes at 72 hours post-rewarming: Bilaterally absent pupillary light reflexes at 72 hours, particularly when confirmed by quantitative pupillometry (NPi <2), are a strong predictor of poor neurological outcome. Combined with other concordant indicators (absent SSEP, malignant EEG, elevated NSE), this finding significantly increases prognostic specificity.^[9]
03

Malignant EEG pattern persisting >24 hours post-rewarming: Burst suppression, suppressed background without reactivity, or status epilepticus refractory to treatment on continuous EEG monitoring >24 hours after completion of rewarming and sedation washout. These patterns indicate severe diffuse cortical dysfunction incompatible with meaningful neurological recovery.^[11]
04

NSE >90 ng/mL at 48–72 hours post-arrest: Markedly elevated NSE at this threshold, after excluding hemolysis, indicates massive neuronal destruction. While NSE should not be used in isolation, values this high — particularly in the context of other poor prognostic indicators — are strongly associated with non-awakening and mortality.^[15]
05

MRI showing diffuse cortical or subcortical diffusion restriction: Extensive bilateral cortical restricted diffusion on DWI, or diffuse deep gray matter (basal ganglia and thalamic) signal abnormality on ADC mapping at 48–72 hours indicates widespread irreversible neuronal death. The extent and distribution of DWI abnormality correlates with the severity of clinical outcome.^[13]
06

Unwitnessed arrest with prolonged no-flow time (>10 min estimated) without bystander CPR; non-shockable initial rhythm with prolonged resuscitation (>30 min): The combination of unwitnessed arrest, non-shockable rhythm (asystole or PEA), absence of bystander CPR, and prolonged resuscitation describes the highest-risk population for severe anoxic injury. While individual exceptions exist, these arrest characteristics alone confer a probability of meaningful neurological recovery approaching zero.^[38]
07

Patient had prior explicit advance directive requesting no artificial life support: A patient who documented, while competent, that they would not want prolonged mechanical ventilation, artificial nutrition, or life in a persistent vegetative state has already made the goals-of-care decision. The surrogate's role is to honor that directive, not to override it. The palliative care team's role is to support the surrogate in carrying out the patient's wishes even when it is emotionally devastating to do so.^[36]
08

Persistent vegetative state at 3 months post-arrest: Anoxic vegetative state is considered permanent at 3 months by the Multi-Society Task Force on PVS. Unlike traumatic brain injury, where late recovery from VS is documented (rarely) up to 12 months, anoxic VS has a negligible probability of meaningful recovery beyond 3 months. Continued life-sustaining treatment in permanent anoxic VS sustains biological function without any prospect of restoring consciousness, awareness, or the capacity for suffering or joy.^[39]
09

Surrogate decision-maker has made an informed decision to transition to comfort care: A surrogate who has received full prognostic disclosure, has been given adequate time for grief and processing (days, not hours), has had access to spiritual care, social work, and palliative medicine consultation, and has arrived at the decision to withdraw life-sustaining treatment has made the most courageous and loving decision a person can make for someone they love. That decision deserves the full support of the medical team — immediate, unhesitating, and without any implication that they are "giving up."^[37]

📋 Clinician note

The hospice clinician who can say clearly, compassionately, and repeatedly to a family — "When the evidence shows the brain injury is severe and permanent, withdrawing life-sustaining treatment is not giving up. It is recognizing that the treatment is no longer serving the person it was meant to help" — is providing one of the most important clinical services in medicine. This sentence must be rehearsed, internalized, and delivered without hesitation. The family needs to hear it from someone who believes it. If you don't believe it yet, sit with it until you do.

S07 Everyone

Out-of-the-Box Approaches

Evidence-graded approaches for the post-cardiac arrest population — communication frameworks, extubation protocols, pharmacologic trials, and structured decision-making tools. Grade A = RCT/guideline-supported; B = multi-observational/meta-analysis; C = limited clinical; D = expert opinion.

Time-Limited Trial Framework

Grade A

Protocol: Define timeframe explicitly — 7–14 days for anoxic injury; define specific clinical milestones (eye tracking, command following, meaningful motor response); define specific reassessment date and communicate to all team members and family

The time-limited trial (TLT) is the gold standard communication and decision-making framework when prognosis is uncertain and the family is not ready to withdraw life-sustaining treatment. The script: "We will continue all current treatment for 14 days and reassess on [specific date]. During this time, we will watch specifically for [eye opening to voice, visual tracking of a family member, following a simple command like 'squeeze my hand']. If these milestones are not met by [date], we will have another family meeting to discuss next steps." TLTs provide structure for hope without indefinite continuation of futile treatment. They are ethically sound, guideline-supported, reduce surrogate decision-making burden, and reduce clinician moral distress by establishing shared expectations. The TLT must be documented in the medical record with the specific milestones and reassessment date.^[30]

Palliative Extubation Protocol

Grade A

Pre-medication: Morphine 5–10 mg IV/SQ 15–30 min before extubation; Midazolam 2–5 mg IV for anxiolysis; Glycopyrrolate 0.2–0.4 mg IV/SQ for secretions. Family present, chaplain present, lights dimmed, monitors silenced.

Comfort extubation — withdrawal of mechanical ventilation with transition to comfort-focused care — is standard of care and an established, guideline-supported practice for ventilator withdrawal in patients with severe anoxic brain injury when goals have shifted to comfort. The process must be unhurried and family-centered. Critical family preparation: the patient may breathe independently for minutes, hours, or occasionally days after extubation. The family who has not been told this will be traumatized — they expected death within minutes and instead witness hours of breathing. Conversely, some patients develop agonal respirations immediately. The family must be prepared for the full range of possibilities. Secretion management with glycopyrrolate or hyoscine is essential to prevent the "death rattle" that causes family distress. Continuous morphine infusion (1–5 mg/hr IV or SQ) should be available for titration to respiratory comfort. The goal is the patient's comfort, not hastening death.^[31]

Family Meeting Communication Framework

Grade A

Protocol: Structured family meeting at 72h post-rewarming; all relevant team members present (intensivist, neurology, palliative care, nursing, social work, chaplaincy); 45–60 min minimum; private, quiet room; no interruptions

Open with what is known, not what is hoped for. Use plain language: "The brain was injured when the heart stopped." Never use the word "vegetable." Present the full spectrum of possible outcomes including vegetative state and minimally conscious state in terms families can understand. The SPIKES or VitalTalk communication framework adapted for post-arrest prognostic disclosure provides structure: Setting, Perception (ask what the family understands), Invitation (ask permission to share information), Knowledge (deliver the information), Emotion (respond to the emotional response — sit in it, don't rush past it), Strategy/Summary. The family meeting question "Will he wake up?" must be answered directly — not deflected, not hedged into meaninglessness. If the answer is "the tests show that the chance of waking up is very small," say that. Silence after delivering prognosis is therapeutic — the clinician who fills silence with words is meeting their own discomfort, not the family's need.^[40]

Amantadine for Disorders of Consciousness

Grade B

Amantadine 100 mg BID via feeding tube (NG or PEG); titrate to 200 mg BID over 2 weeks; maximum 400 mg/day; reassess at 4–6 weeks

The TRAMMS trial (Giacino et al., New England Journal of Medicine, 2012) demonstrated that amantadine 100–200 mg BID accelerated the pace of functional recovery in patients with traumatic disorders of consciousness (VS and MCS) at 4–16 weeks post-injury compared to placebo. Patients on amantadine showed faster improvement on the Disability Rating Scale during treatment, though the groups converged after washout. Critical caveat: the evidence base is primarily from traumatic brain injury, not anoxic brain injury. The pathophysiology of anoxic injury (diffuse neuronal death) differs fundamentally from traumatic injury (diffuse axonal injury with potential for axonal regeneration). Evidence for amantadine in anoxic etiology is limited to case series and expert opinion. It is used off-label in selected patients with anoxic disorders of consciousness who are in a time-limited trial with defined milestones. Not appropriate in patients with comfort-only goals. Should be discussed with neurology before initiation. Contraindicated in seizure-prone patients without adequate anticonvulsant coverage.^[41]

S08Everyone

Natural & Herbal Options

Evidence grading, dosing where supported, drug interaction flags, and explicit contraindications specific to post-cardiac arrest patients. Most supplement decisions in this population are made on behalf of an incapacitated patient.

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"Post-cardiac arrest patients on hospice are mostly non-verbal with feeding tubes. Every supplement goes through that tube. The question is not 'does the family want to try something' — the question is 'does this help or does it interact with the levetiracetam and the morphine.' Have that conversation before anything goes into the tube."

— Waldo, NP

⚕ Supplement Considerations in Post-Cardiac Arrest

Post-cardiac arrest patients receiving hospice care present unique supplement challenges. If the patient is in a minimally conscious or vegetative state with a feeding tube, supplements are administered enterally — verify compatibility with the feeding tube and enteral medication route. The primary symptom management targets are seizure threshold, neuroprotection, and caregiver/family support rather than patient-directed supplement therapy. Most supplement decisions are made on behalf of an incapacitated patient — apply strict substituted judgment or best interests standards.

Herb / Supplement	Evidence Grade	Typical Dose	Potential Benefit	⚠ Interactions / Contraindications
Melatonin (via feeding tube)	Grade C	3–10 mg nightly via tube	Neuroprotective preclinical signal in hypoxic-ischemic injury; antioxidant and anti-apoptotic; may reduce secondary neuroinflammation; increasingly used off-label in neuro ICU	Safe; minimal drug interactions; discuss with medical director
Magnesium glycinate (via feeding tube)	Grade C	200–400 mg daily via tube	Neuroprotective via NMDA receptor antagonism; corrects documented hypomagnesemia which worsens seizure threshold	Monitor levels; no significant interactions at standard dose; may cause loose stools
Omega-3 fatty acids (via feeding tube)	Grade C	1 g/day fish oil via tube	DHA/EPA have neuroprotective properties in brain injury models; some clinical data from TBI literature; less specific evidence for anoxic injury	Minimal interactions; generally safe; may increase bleeding risk at high doses
CoQ10 (via feeding tube)	Grade D	100–200 mg BID via tube	Mitochondrial support in ischemia-reperfusion context; theoretical neuroprotection; very limited clinical data for anoxic injury	Generally safe; may reduce warfarin efficacy; discuss with medical director
Valerian root or chamomile tea (via tube or oral)	Grade D	Valerian 300–600 mg nightly; chamomile tea PRN	Mild sedation; may support sleep-wake cycle regulation; primarily for caregiver anxiety support rather than patient benefit	Additive CNS depression with benzodiazepines and opioids
CBD oil (via feeding tube)	Grade D	Variable; typically 25–50 mg BID	Anticonvulsant properties demonstrated in Dravet/Lennox-Gastaut; theoretical seizure threshold benefit; very limited data in post-arrest	Significant CYP3A4 and CYP2C19 inhibition — interacts with levetiracetam metabolism; discuss with medical director

🚫 Avoid in Post-Cardiac Arrest Patients

St. John's Wort: Induces CYP3A4 — reduces levels of multiple medications including antiepileptics; contraindicated with seizure medications
Ginkgo biloba: Antiplatelet and proconvulsant effects — increases bleeding risk and may lower seizure threshold
Kava: Hepatotoxic and potentiates CNS depressants including opioids and benzodiazepines used in comfort care
High-dose vitamin E (>400 IU): Increases bleeding risk; no demonstrated neuroprotective benefit at this stage

S09Everyone

Timeline Guide

A guide to the post-cardiac arrest trajectory — from ICU resuscitation through prognostication, through goals-of-care decisions, through comfort care or long-term care for disorders of consciousness.

This timeline is unique because it begins with a single acute event — the cardiac arrest — and the trajectory depends entirely on the severity of the anoxic brain injury. There is no years-long decline. There is a catastrophic event, followed by days to weeks of assessment, followed by either recovery, transition to comfort, or transition to long-term care in a vegetative or minimally conscious state.^[6]

YRS–
MOS

Long-Term Care / Disorders of Consciousness

For patients who survive to MCS or VS and are discharged to long-term care, this phase represents months to years of care
Regular reassessment of goals; management of complications (pressure injuries, recurrent pneumonia, contractures, seizures)
Family support for the grief of long-term VS/MCS — this grief has no resolution and no endpoint
Periodic revisiting of advance directive and goals — families may change their minds as they live with the reality
The hospice clinician in this phase is a longitudinal presence managing complications, not cure

MOS

ICU Phase (Days 1–14)

Acute resuscitation and stabilization; TTM completed; coronary intervention if indicated^[3]
Prognostic assessment at 72h post-rewarming using multimodal approach^[7]
Family meetings beginning; time-limited trial may be established^[39]
Palliative care team's primary role: family communication support and goals clarification
Many patients die in ICU during this phase after withdrawal of life-sustaining treatment^[24]
Some transition to persistent VS or MCS requiring rehabilitation or long-term care decisions^[10]

WKS

Subacute Phase (Weeks 2–8)

Patients who have not recovered are beyond the acute window
If still on ventilator: tracheostomy and PEG decisions
Rehabilitation assessment for MCS patients^[12]
If no neurological improvement: second major goals-of-care conversation
Transition decisions: home hospice, long-term acute care, skilled nursing, inpatient hospice
Seizure management optimization; skin integrity assessment; nutritional planning via PEG

DAYS–
WKS

Comfort Transition / Pre-Active Dying

Patients whose families have chosen comfort care after prognostic disclosure
Palliative extubation preparation and execution^[38]
Comfort medication titration: morphine, midazolam, glycopyrrolate
Home hospice setup if patient survives extubation and transitions home
Intensive family support — the grief of watching someone breathe who is no longer reachable
Feeding decisions: artificial nutrition may be continued or withdrawn depending on goals

HRS–
DAYS

Final Hours

Death may follow extubation within minutes to hours, or patient may survive and die later
Breathing pattern changes: Cheyne-Stokes, agonal breathing, mandibular breathing
Mottling, cooling extremities, loss of peripheral pulses
Seizure risk persists — have midazolam drawn and at bedside
Family needs to be told: "This is the body shutting down. This is expected. You are not watching suffering."
Quiet room, familiar voices, familiar music; auditory awareness may persist

S10Clinician

Medications to Anticipate

Symptom-targeted pharmacology for post-cardiac arrest patients. Two distinct contexts: ICU comfort extubation (death expected hours to days) and home hospice with VS/MCS patient (care may extend weeks to months).

🚨 Two Distinct Medication Contexts

Post-cardiac arrest patients receiving hospice care present two distinct medication contexts: (1) the patient in the ICU transitioning to comfort care — medications are IV, death expected hours to days after ventilator withdrawal; and (2) the patient discharged home in VS or MCS on a feeding tube — care may extend weeks to months. The medication priorities differ completely. For context 1: palliative sedation and comfort extubation medications. For context 2: seizure management, infection prevention, and tube-route medication management. Identify which context you are managing before the first visit.

Drug	Class / Target Symptom	Starting Dose	Notes / Cautions
Morphine IV or SQ	Opioid / Comfort Extubation & Dyspnea	5–10 mg IV or SQ pre-extubation; titrate to comfort	The medication that converts what could be a distressing death into a peaceful one. Do not underdose. A dying patient showing distress needs more morphine, not reassurance.^[38]
Midazolam IV or SQ	Benzodiazepine / Sedation & Terminal Agitation	2–5 mg IV pre-extubation; CSCI 10–20 mg/24h post-extubation	For comfort extubation and terminal agitation. Home hospice: buccal or intranasal for acute seizure rescue.
Levetiracetam (via tube or IV)	Antiepileptic / Seizure Management	500–1500 mg BID via tube or IV	Post-arrest seizures and NCSE worsen neurological outcomes. Renally adjusted. First-line for post-arrest seizure prophylaxis. ⚠ Caution: behavioral side effects (agitation, irritability) — difficult to distinguish from brain injury behaviors^[6]
Lorazepam (buccal or rectal)	Benzodiazepine / Home Seizure Rescue	0.5–1 mg buccal for acute seizure	Family must be trained before discharge. Intranasal midazolam 5 mg is alternative. Have rescue medication at bedside at all times.
Glycopyrrolate	Anticholinergic / Terminal Secretions	0.2 mg SQ q4h	Reduces secretions without CNS effects. Preferred in patients with any residual consciousness. Essential during and after comfort extubation.
Dexamethasone (IV or via tube)	Corticosteroid / Cerebral Edema	4–8 mg IV/PO BID; taper if >2 weeks	For cerebral edema causing increased ICP symptoms. Not appropriate in comfort-only patients near death. Taper to avoid adrenal crisis.
Baclofen (via feeding tube)	Muscle Relaxant / Spasticity	5–10 mg TID via tube; titrate slowly	Spasticity and posturing in VS/MCS patients. Start low, titrate slow. ⚠ Caution: abrupt withdrawal causes seizures and hyperthermia
Acetaminophen (via tube or rectal)	Analgesic-Antipyretic / Fever & Comfort	650–1000 mg q6h via tube or rectally	Fever prevention is essential post-arrest. Also for baseline comfort analgesia. Maximum 3 g/day; adjust for hepatic impairment.
Metoclopramide (via tube)	Prokinetic / Feeding Intolerance	10 mg via tube q6h before feeds	Gastric dysmotility common in neurologically injured patients. Promotes gastric emptying for tube feeds. ⚠ Caution: contraindicated in complete bowel obstruction; risk of tardive dyskinesia with prolonged use

🚨 Comfort Kit Must-Haves

Morphine 20 mg/mL concentrate (for SQ injection during/after extubation or home comfort); Midazolam 5 mg/mL (for terminal agitation and seizure rescue); Glycopyrrolate 0.2 mg/mL (for secretions during/after extubation); Lorazepam 2 mg/mL (buccal seizure rescue — family-trained); Acetaminophen suppositories 650 mg (fever/comfort when tube is not accessible)

ℹ Decision Tree Note

The symptom management decision tree below covers general hospice symptom management — pain, dyspnea, nausea, agitation, secretions, and anxiety. These pathways apply broadly across hospice diagnoses. The medications in the table above are specific to the post-cardiac arrest population, including comfort extubation medications, seizure management, and tube-route considerations unique to this diagnosis.

🌿 Symptom Management Decision Tree

Evidence-based · Hospice-adapted

Select a symptom below to begin

What is the primary symptom to address?

S11Clinician

Clinician Pointers

High-yield clinical pearls for the hospice team managing post-cardiac arrest and anoxic brain injury. The things not in the textbook — learned in ICU family meetings and beside feeding tubes in living rooms.

1

Assess family understanding before delivering prognosis

The family does not understand the difference between cardiac survival and neurological recovery. Ask: "What have the doctors told you about what happens to the brain when the heart stops for that long?" Building on a correct foundation takes minutes; rebuilding from an incorrect one takes hours and is emotionally brutal.^[44]

2

Multimodal prognostication at 72h is the standard — no single test is sufficient

The family told "the brain wave test shows no activity" deserves to understand prognostication uses multiple tools. Conversely, if bilateral N20 absence has been found, the family deserves the honesty that the most powerful prognostic tool has shown very poor outcome. Translate the tests into honest language.^[7]^[16]

3

The time-limited trial is the ethical gold standard

Never present the choice as "continue everything vs. give up." Present: "we continue care while gathering more information for [specific timeframe] and reassess based on [specific milestones]." Document TLT terms in the chart. Hold the follow-up meeting on the agreed date.^[39]

4

Comfort extubation preparation begins before the family says yes

Comfort medications drawn, room prepared, chaplain called, family briefed on what happens after ventilator removal — the family who watches breathing continue for 3 hours without being told that could happen is traumatized; the family who was told is not.^[38]

5

The open eyes in VS are not seeing — explain at every visit

Explain what each behavioral sign means and does not mean. The family who misinterprets open eyes as waking up will not be ready for the comfort care conversation when it comes. Document your assessment of consciousness level at every visit.^[10]^[12]

6

Black families face compounded disadvantage in cardiac arrest

Lower bystander CPR rates, longer EMS response times, lower shockable rhythm rates, lower ICU admission rates, higher in-hospital mortality. Address trust deficits directly. Ensure prognostic conversations are documented and equitably delivered. Advocate for equal access to palliative care consultation.^[28]^[29]^[30]

7

Seizures in VS/MCS patients at home terrify families

Train the family before discharge: show them the rescue medication, rehearse the administration, explain what a seizure looks like, what to do, what not to do, when to call 911, when to call hospice. The family who has rehearsed is functional in the crisis; the family who hasn't is paralyzed.

8

The feeding tube question will come back repeatedly

Artificial nutrition in VS is one of the most emotionally charged decisions in medicine. The family who chose PEG placement during the hope phase may later question it. Do not avoid this conversation. Revisit it gently and periodically: "How do you feel about how the feeding is going? Is this still what you think [patient's name] would want?"

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"The ICU team speaks in numbers. The family hears in feelings. Your job is translation — not from medical to simple, but from measured to meaningful. When the neurologist says 'bilateral absent N20,' the family hears noise. When you say 'the test that checks whether signals from the body reach the brain showed that they are not reaching it,' the family hears their future changing. Say it. Sit in it. Do not rush to the next sentence."

— Waldo, NP · Terminal2

S12EveryoneClinician

Psychosocial & Spiritual Care

The psychological and spiritual landscape of post-cardiac arrest care — survivor guilt, surrogate decision grief, ambiguous loss, and the specific spiritual crisis of watching someone breathe who is no longer reachable.

The psychosocial burden of post-cardiac arrest care is among the most intense in all of hospice and palliative medicine. Unlike progressive diseases where grief builds gradually, cardiac arrest delivers catastrophe, hope, and devastation in rapid succession. The family who performed CPR, who watched the code, who celebrated the heartbeat returning, and then learned the brain was destroyed is navigating a trauma sequence that few clinical encounters address explicitly.^[26]

Survivor Guilt & Witness Trauma

Survivor Guilt in the Resuscitating Family Member

Grade B

The person who was present — who called 911, who performed CPR or did not, who delayed calling — carries devastating guilt regardless of what they did. Address directly: "I want you to know that the outcome of cardiac arrest is determined by factors no single person can control. The time between when the heart stops and when blood returns to the brain is measured in minutes. You called 911. You did what you could. The outcome is not a measure of what you did or did not do." Screen for PTSD.^[15]

The Shock of Survival Followed by Devastating Diagnosis

Grade B

The family experienced: (1) acute catastrophe, (2) CPR as miracle, (3) "heart is beating" as relief, (4) brain injury as second catastrophe. This emotional whiplash requires specific acknowledgment. They celebrated a survival that turned out not to be what they celebrated. Name this sequence explicitly. Validate the complexity.^[26]

Surrogate Decision-Making & Ambiguous Loss

Surrogate Decision-Making Grief

The family member asked to decide about withdrawing LST carries one of the heaviest burdens in medicine. They experience guilt regardless of decision. Explicit permission: "You are not deciding to end your person's life; you are deciding what treatment your person would want, based on everything you know about them. That is the most loving act." Recommend surrogate support group or counseling referral.^[26]

Ambiguous Loss (Boss Framework)

The patient is physically present but psychologically absent. The family cannot grieve because the person is not dead; they cannot hope because the person is not recoverable. This is ambiguous loss — coined by Pauline Boss. It is one of the most complex grief experiences in medicine. Name it for the family: "What you are feeling — this terrible in-between — has a name. It is called ambiguous loss." Naming it reduces its power.^[25]

Spiritual Assessment

FICA framework adapted for post-arrest. The spiritual crisis in cardiac arrest families is often: "Why did God let this happen?" or "If God saved the heart, why not the brain?" Do not answer these questions. Create space for them. Chaplain involvement at first encounter, not at crisis. For families of faith: "continuing to love and be present is a form of prayer." For families without religious tradition: meaning, legacy, connection.^[37]

Clinical Pearl

The family who sits at the bedside of a VS patient talking to them, playing their music, holding their hand — they are not in denial. They are loving. Do not pathologize love. Support it. It is therapeutic for the family even when it cannot reach the patient.

Goals-of-Care Communication

Opening the Conversation

"What is your understanding of what happened to [name]'s brain?" — assesses illness understanding before prognostic disclosure
"What are you hoping for at this point?" — surfaces values, not just preferences
"What would [name] have said about being kept alive on machines?" — invokes substituted judgment
"If the tests show that the brain injury is permanent, what do you think [name] would want?" — reframes around the patient's known values^[44]

Communication Pitfalls

Don't say "brain dead" unless the patient meets actual brain death criteria — conflating VS/MCS with brain death causes enormous confusion and erodes trust^[32]
Don't say "vegetable" ever — dehumanizing language destroys the therapeutic relationship
Don't promise recovery when evidence shows otherwise — false hope is not compassion
Don't rush the conversation — this family needs to hear it multiple times before it integrates
Don't have this conversation with one family member — get the whole family together; fragmented information causes conflict

Suicidal Ideation & Caregiver Mental Health

Surrogate decision-makers who authorized ventilator withdrawal are at elevated risk for complicated grief, PTSD, and suicidal ideation. Screen at every bereavement visit. The grief of having "decided" to end life-sustaining treatment — even when that decision was clearly aligned with the patient's values — carries a psychological burden that persists for years. Mirtazapine 7.5 mg QHS for concurrent depression, insomnia, and anorexia in caregivers — addresses multiple symptoms simultaneously with faster onset than SSRIs.^[26]^[35]

From the Field

Waldo Rios, NP

Hospice NP · 12+ Years

"I've been in the room when the ventilator was turned off. I've been in the room when the family watched their person keep breathing and didn't know whether to be relieved or terrified. I've been in the room three weeks later when the family at home realized that the person in the hospital bed in their living room was never going to say their name again. The grief changes shape, but it never gets smaller. Your job is not to shrink it. Your job is to sit in it with them and make sure they know they are not alone in it."

— Waldo, NP · Terminal2

S13FamilyEveryone

Family Guide

Plain language for families caring for a loved one after cardiac arrest and anoxic brain injury. Share, print, or read aloud at the bedside.

Your loved one survived a cardiac arrest — and we know that word "survived" may feel complicated right now. The heart was restarted, but the brain was without oxygen for long enough to cause serious injury. What you are seeing now — the breathing, the eyes opening and closing, the movements — may not mean what you hope it means. Your hospice team is here to help you understand what is happening, what to expect, and how to care for your person with dignity and love.

Próximamente en español. — Coming soon in Spanish.

What You May See

Eyes open but not seeming to see — in severe brain injury the eyes can open without the brain being aware; this is not the same as waking up; your nurse will explain what is and is not awareness
Sleep-wake cycles — periods of eyes open during the day and closed at night; driven by the brain stem, not consciousness; expected and does not indicate recovery
Groaning or vocalizing — reflexive sounds from the brain stem; not expressions of pain or communication in severe injury; report any sound that looks like distress
Apparent facial expressions — frowning, grimacing, or what looks like smiling; subcortical reflexive movements; not necessarily pain or happiness; report distress signs
Spasms or seizures — stiffening, shaking, twitching; your nurse has provided emergency seizure medication and instructions; call the nurse after any seizure
Changes in breathing — periods of faster or slower breathing, sometimes pauses; expected with severe brain injury

How You Can Help

Talk to your person — hearing may be the last sense to go; familiar voices, music, reading aloud may provide comfort; your presence matters even without visible response
Provide sensory enrichment — music from their life, a favorite scent, gentle touch; these are acts of love that have meaning regardless of response
Follow the feeding tube protocol your nurse reviewed — give medications and nutrition as instructed; report tube blockages, leaking, or redness around the tube site
Reposition every 2 hours — your nurse has shown you how; this prevents pressure injuries which are painful and can lead to infections
Keep the mouth moist — use the oral care swabs provided; dry mouth causes discomfort even in unconscious patients
Take care of yourself — what you are carrying is extraordinarily heavy; call us when you need support, not just when the patient does; respite care is available

📞 Call the nurse immediately if you see:

A seizure lasts more than 5 minutes or occurs repeatedly without recovery between episodes. Breathing stops for more than 30 seconds or changes dramatically. Fever above 101.5°F that does not respond to acetaminophen. The feeding tube comes out, becomes blocked, or leaks around the insertion site. You see new redness, swelling, or open areas on the skin that were not there before. Your loved one appears to be in pain — facial grimacing, moaning, or restlessness that is different from usual.

🙏 You are doing something extraordinary. Caring for someone who cannot tell you they feel your presence is one of the most selfless acts a human being can perform. Research shows that patients with devoted family caregivers have fewer complications, fewer infections, and more peaceful deaths. You are part of the care team. You matter more than you know.

S14Everyone

Waldo's Top 10 Tips

Clinical field wisdom from 12+ years at the bedside. The things you learn after doing this long enough. Not guidelines — real.

01
The family meeting question "will he wake up?" must be answered directly — most clinicians circle it; the family knows you're circling it; the circling increases their terror. Say what you know: "Based on all the tests we have done, the likelihood of meaningful recovery is very low." Then stop talking and sit in the silence. The grief that follows that silence is the beginning of the most important conversation you will have with this family. Do not fill the silence with statistics. Let them feel it first.
02
The time-limited trial is the ethical gold standard — never offer "continue everything vs. give up." Always offer "we continue everything for this specific timeframe and assess on this specific date based on these specific milestones." The TLT gives the family something to do with their hope while establishing a decision-making framework. Document it. Hold the follow-up meeting. If you don't hold the meeting, the TLT becomes open-ended treatment, which is exactly what it was designed to prevent.
03
Prepare the comfort extubation before the family says yes — comfort medications drawn, room prepared, chaplain called, family briefed on what happens after the ventilator is removed. The family who watches their person continue breathing for three hours after extubation without having been told that could happen is traumatized. The family who was told that this is normal and expected is sad but not traumatized. The difference is preparation, and preparation is your job.
04
The open eyes in VS are not seeing — explain at every visit what each behavioral sign means and does not mean. The family who misinterprets open eyes as waking up will not be ready for the comfort care conversation when it comes. The family who asks "but his eyes are open — doesn't that mean he's in there?" deserves the truth: "The eyes opening is controlled by a part of the brain that survived. The part of the brain that sees, that recognizes, that understands — that part was more severely injured. Open eyes do not mean awareness."
05
Bilateral absent N20 SSEP is the most powerful prognostic tool and must be communicated honestly — if this finding has been documented, you must understand what it means and be able to say: "The test that measures whether the nerve signal from the body is reaching the brain showed no signal arriving. In medical studies, when this test shows this result, meaningful recovery has not occurred." Do not soften this into uselessness. The family needs the truth delivered with compassion, not compassion delivered without truth.
06
Seizures at home terrify families — train them before it happens. Show them the rescue medication. Make them practice putting the syringe in the cheek. Tell them what a seizure looks like: "You may see sudden stiffening, shaking, eyes rolling, drooling, possibly blue lips. It will look terrifying. It is usually not dangerous if it stops within five minutes." Tell them what to do. Tell them what not to do. The family who has rehearsed is functional in the crisis. The family who hasn't is calling 911 and undoing the hospice plan.
07
The feeding tube question will come back — the family who chose PEG placement during the hope phase may question it later. That is not inconsistency; that is growth. They are living with a reality they could not have imagined when they said yes to the tube. Do not avoid this conversation. Revisit it every few weeks: "How do you feel about how the feeding is going?" The answer tells you where they are in their grief journey and whether the goals of care need to be revisited.
08
Black families and other communities of color face compounded disadvantage — lower bystander CPR rates in their neighborhoods, longer EMS response times, less likely to receive shockable-rhythm-first care, higher mortality. Then they arrive in an ICU system where they are less likely to receive palliative care consultation and more likely to be offered aggressive care without adequate prognostic disclosure. Recognize this. Name it when appropriate. Ensure your prognostic conversations are equitable, documented, and delivered with the same honesty to every family regardless of race.
09
The caregiver at home with a VS patient is carrying a weight that no one sees — they are providing total care for a person who cannot acknowledge them, in a home that has become a hospital room, with a grief that has no resolution and no endpoint. Screen for depression at every visit. Offer respite proactively, not reactively. Say explicitly: "You are allowed to be exhausted. You are allowed to be angry. You are allowed to grieve someone who is still breathing. All of those things are normal and none of them mean you love your person any less."
10
Every visit with this family is a visit with grief — not the clean grief of death, but the messy grief of ambiguity. They are watching someone they love breathe without being present. They are feeding someone through a tube who used to cook Sunday dinner. They are turning someone every two hours who used to hold them. This is not a clinical scenario. This is a family's life, rearranged around a catastrophe. Be worthy of the room you are allowed to enter. Be honest. Be present. Be human. That is the medicine.

— Waldo, NP

REFClinician

References

Peer-reviewed citations. Based on articles retrieved from PubMed. All PMIDs hyperlinked. Evidence levels assigned by article type.

1

Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics — 2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–e528.

PMID 30700139 Guideline

2

Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics — 2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–e596.

PMID 31992061 Guideline

3

Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–556.

PMID 11856793 RCT

4

Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013;369(23):2197–2206.

PMID 24237006 RCT

5

Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283–2294.

PMID 34133859 RCT

6

Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and ESICM guidelines 2021: post-resuscitation care. Resuscitation. 2021;161:220–269.

PMID 33773827 Guideline

7

Sandroni C, Cariou A, Cavallaro F, et al. Prognostication in comatose survivors of cardiac arrest: an advisory statement from ERC and ESICM. Intensive Care Med. 2014;40(12):1816–1831.

PMID 25398304 Guideline

8

Wijdicks EFM, Hijdra A, Young GB, et al. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review). Neurology. 2006;67(2):203–210.

PMID 16864809 Guideline

9

Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol. 2010;67(3):301–307.

PMID 20373341 Observational

10

Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state (Part 1). N Engl J Med. 1994;330(21):1499–1508.

PMID 7818633 Review

11

Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state (Part 2). N Engl J Med. 1994;330(22):1572–1579.

PMID 8177248 Review

12

Giacino JT, Ashwal S, Childs N, et al. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002;58(3):349–353.

PMID 11839831 Guideline

13

Giacino JT, Whyte J, Bagiella E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366(9):819–826.

PMID 22375973 RCT

14

Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA. 1999;281(13):1182–1188.

PMID 10199427 Observational

15

Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300(12):1423–1431.

PMID 18812533 Observational

16

Geocadin RG, Callaway CW, Fink EL, et al. Standards for studies of neurological prognostication in comatose survivors of cardiac arrest: a scientific statement from the AHA. Resuscitation. 2019;140:99–113.

PMID 31075362 Guideline

17

Cronberg T, Rundgren M, Westhall E, et al. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology. 2011;77(7):623–630.

PMID 21775737 Observational

18

Stammet P, Collignon O, Hassager C, et al. Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33°C and 36°C. J Am Coll Cardiol. 2015;65(19):2104–2114.

PMID 25975474 Observational

19

Hirsch KG, Mlynash M, Eyngorn I, et al. Multi-center study of diffusion-weighted imaging in comatose cardiac arrest patients. Neurocrit Care. 2016;24(1):82–89.

PMID 26136148 Observational

20

Taccone FS, Cronberg T, Friberg H, et al. Death after awakening from post-anoxic coma: the "Best CPC" project. Crit Care. 2019;23(1):107.

PMID 30925924 Observational

21

Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16_suppl_2):S366–S468.

PMID 33081529 Guideline

22

Perkins GD, Graesner JT, Semeraro F, et al. European Resuscitation Council Guidelines 2021: Executive summary. Resuscitation. 2021;161:1–60.

PMID 33773824 Guideline

23

Callaway CW, Donnino MW, Fink EL, et al. Part 8: Post–Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Suppl 2):S465–S482.

PMID 26472996 Guideline

24

Dragancea I, Rundgren M, Englund E, et al. The influence of induced hypothermia and delayed prognostication on the mode of death after cardiac arrest. Resuscitation. 2017;117:50–57.

PMID 28576547 Observational

25

Boss P. Ambiguous Loss: Learning to Live with Unresolved Grief. Harvard University Press. 1999.

Expert

26

Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions for others. Ann Intern Med. 2011;154(5):336–346.

PMID 21357911 Systematic Review

27

Anderson WG, Chase R, Pantilat SZ, et al. Code status discussions between attending hospitalist physicians and medical patients at hospital admission. J Gen Intern Med. 2011;26(4):359–366.

PMID 21104036 Observational

28

Becker LB, Han BH, Meyer PM, et al. Racial differences in the incidence of cardiac arrest and subsequent survival. N Engl J Med. 1993;329(9):600–606.

PMID 8341333 Observational

29

Chan PS, Nichol G, Krumholz HM, et al. Racial differences in survival after in-hospital cardiac arrest. JAMA. 2009;302(11):1195–1201.

PMID 19755698 Observational

30

Blewer AL, Ibrahim SA, Leary M, et al. Cardiopulmonary resuscitation training disparities in the United States. J Am Heart Assoc. 2020;9(8):e015443.

PMID 32308119 Observational

31

Perman SM, Kirkpatrick JN, Reitsma AM, et al. Timing of neuroprognostication in postcardiac arrest therapeutic hypothermia. Neurology. 2014;83(3):261–267.

Observational

32

Greer DM, Shemie SD, Lewis A, et al. Determination of brain death/death by neurologic criteria: The World Brain Death Project. JAMA. 2020;324(11):1078–1097.

PMID 32761206 Guideline

33

Elmer J, Torres C, Englesbe MJ, et al. Association of early withdrawal of life-sustaining therapy for perceived neurological futility with survival after cardiac arrest. Resuscitation. 2016;102:127–135.

PMID 26836944 Observational

34

Quill TE, Back AL, Block SD. Responding to patients requesting physician-assisted death: guidance for health care professionals. Ann Intern Med. 2016;165(3):218–219.

Expert

35

Chochinov HM, Hack T, Hassard T, et al. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol. 2005;23(24):5520–5525.

PMID 16110012 RCT

36

Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.

PMID 20818875 RCT

37

Puchalski CM, Vitillo R, Hull SK, Reller N. Improving the spiritual dimension of whole person care: reaching national and international consensus. J Palliat Med. 2014;17(6):642–656.

PMID 24842136 Review

38

Robert R, Le Gouge A, Kentish-Barnes N, et al. Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study). Intensive Care Med. 2017;43(12):1793–1807.

PMID 28936597 Observational

39

Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011;306(13):1483–1484.

PMID 21972312 Expert

40

Frontera JA, Cronberg T, Engström M, et al. Withdrawn care and death after cardiac arrest: a post-hoc analysis of the TTM2 trial. Intensive Care Med. 2023;49(2):158–169.

Observational

41

Tong JT, Estraneo A, Moretta P, et al. Sensory stimulation for patients in disorder of consciousness: a systematic review. Brain Inj. 2022;36(2):141–152.

Systematic Review

42

Finley Caulfield A, Singh TD, Muehlschlegel S, et al. S100B and neuron-specific enolase as predictors of outcome after cardiac arrest. Neurocrit Care. 2011;14(3):406–412.

PMID 20524090 Observational

43

Morrison RS, Meier DE. Palliative care. N Engl J Med. 2004;350(25):2582–2590.

PMID 15201415 Review

44

Muehlschlegel S, Perman SM, Gowda A, et al. Goals-of-care decision aid for critically brain-injured patients: development and feasibility testing (GUIDE). Neurology. 2020;95(11):e1453–e1463.

RCT

45

Claassen J, Doyle K, Matory A, et al. Detection of brain activation in unresponsive patients with acute brain injury. N Engl J Med. 2019;380(26):2497–2505.

PMID 31242361 RCT

terminal2.care content is for educational purposes and is not a substitute for clinical judgment. Based on articles retrieved from PubMed. © Terminal2 | terminal2.care

📝

Private Notes

Session notes — not saved to any server. Clears when you close the tab.

Use this space for visit notes, clinical reminders, or patient-specific observations. This text is stored only in your browser session.